+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Clinical Trial Supplies Market 2023-2027

  • PDF Icon

    Report

  • 162 Pages
  • August 2023
  • Region: Global
  • TechNavio
  • ID: 5120713
1h Free Analyst Time
Description Jump to:

Growing Demand for CROS is a Key Trend Gaining Market Momentum

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The global clinical trial supplies market is forecasted to grow by USD 1.19 billion during 2022-2027, accelerating at a CAGR of 8.48% during the forecast period. The market is driven by growth of biopharmaceutical industry, government initiatives on clinical research, and regulation of clinical trials in regional markets.

This report on the clinical trial supplies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment.

The global clinical trial supplies market is segmented as below:

By End-user

  • Pharmaceutical industry
  • Biologics industry
  • Medical device industry

By Type

  • Phase III
  • Phase II
  • Phase IV and BE/BA studies
  • Phase I

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing demand for CROS as one of the prime reasons driving the clinical trial supplies market growth during the next few years. Also, increase in studies focusing on pharmaceutical industry and rising demand for e-clinical trials will lead to sizable demand in the market.

The report on the clinical trial supplies market covers the following areas:

  • Clinical trial supplies market sizing
  • Clinical trial supplies market forecast
  • Clinical trial supplies market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading clinical trial supplies market vendors that include Avantor Inc., Bionical Emas Group, Bushu Pharmaceuticals Ltd., Catalent Inc., Clinical Services International Ltd., Clinigen Group Plc, Deutsche Bahn AG, Emsere B.V, GNH India Pharmaceuticals Ltd., International Bonded Couriers Inc., Nuvisan GmbH, Obvio Health USA Inc., Parexel International Corp., PHOENIX Pharmahandel GmbH and Co KG, Piramal Enterprises Ltd., Thermo Fisher Scientific Inc., Vertical Pharma Resources Ltd., Ancillare LP, PCI Pharma Services, and Precision Medicine Group LLC. Also, the clinical trial supplies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
  • Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global clinical trial supplies market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on global clinical trial supplies market 2017 - 2021 ($ million)
4.2 End-user Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by End-user
6.1 Market segments
  • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
6.2 Comparison by End-user
  • Exhibit 32: Chart on Comparison by End-user
  • Exhibit 33: Data Table on Comparison by End-user
6.3 Pharmaceutical industry - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
6.4 Biologics industry - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Biologics industry - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Biologics industry - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Biologics industry - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Biologics industry - Year-over-year growth 2022-2027 (%)
6.5 Medical device industry - Market size and forecast 2022-2027
  • Exhibit 42: Chart on Medical device industry - Market size and forecast 2022-2027 ($ million)
  • Exhibit 43: Data Table on Medical device industry - Market size and forecast 2022-2027 ($ million)
  • Exhibit 44: Chart on Medical device industry - Year-over-year growth 2022-2027 (%)
  • Exhibit 45: Data Table on Medical device industry - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by End-user
  • Exhibit 46: Market opportunity by End-user ($ million)
  • Exhibit 47: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Type
7.1 Market segments
  • Exhibit 48: Chart on Type - Market share 2022-2027 (%)
  • Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
  • Exhibit 50: Chart on Comparison by Type
  • Exhibit 51: Data Table on Comparison by Type
7.3 Phase III - Market size and forecast 2022-2027
  • Exhibit 52: Chart on Phase III - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Data Table on Phase III - Market size and forecast 2022-2027 ($ million)
  • Exhibit 54: Chart on Phase III - Year-over-year growth 2022-2027 (%)
  • Exhibit 55: Data Table on Phase III - Year-over-year growth 2022-2027 (%)
7.4 Phase II - Market size and forecast 2022-2027
  • Exhibit 56: Chart on Phase II - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Data Table on Phase II - Market size and forecast 2022-2027 ($ million)
  • Exhibit 58: Chart on Phase II - Year-over-year growth 2022-2027 (%)
  • Exhibit 59: Data Table on Phase II - Year-over-year growth 2022-2027 (%)
7.5 Phase IV and BE/BA studies - Market size and forecast 2022-2027
  • Exhibit 60: Chart on Phase IV and BE/BA studies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 61: Data Table on Phase IV and BE/BA studies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 62: Chart on Phase IV and BE/BA studies - Year-over-year growth 2022-2027 (%)
  • Exhibit 63: Data Table on Phase IV and BE/BA studies - Year-over-year growth 2022-2027 (%)
7.6 Phase I - Market size and forecast 2022-2027
  • Exhibit 64: Chart on Phase I - Market size and forecast 2022-2027 ($ million)
  • Exhibit 65: Data Table on Phase I - Market size and forecast 2022-2027 ($ million)
  • Exhibit 66: Chart on Phase I - Year-over-year growth 2022-2027 (%)
  • Exhibit 67: Data Table on Phase I - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by Type
  • Exhibit 68: Market opportunity by Type ($ million)
  • Exhibit 69: Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
8.1 Customer landscape overview
  • Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
  • Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
  • Exhibit 73: Chart on Geographic comparison
  • Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
  • Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
  • Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
  • Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
  • Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
  • Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
  • Exhibit 107: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 108: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 109: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibit 110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
  • Exhibit 111: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
  • Exhibit 113: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
  • Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
  • Exhibit 115: Overview on factors of disruption
11.4 Industry risks
  • Exhibit 116: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
  • Exhibit 117: Vendors covered
12.2 Market positioning of vendors
  • Exhibit 118: Matrix on vendor position and classification
12.3 Ancillare LP
  • Exhibit 119: Ancillare LP - Overview
  • Exhibit 120: Ancillare LP - Product / Service
  • Exhibit 121: Ancillare LP - Key offerings
12.4 Avantor Inc.
  • Exhibit 122: Avantor Inc. - Overview
  • Exhibit 123: Avantor Inc. - Business segments
  • Exhibit 124: Avantor Inc. - Key offerings
  • Exhibit 125: Avantor Inc. - Segment focus
12.5 Bushu Pharmaceuticals Ltd.
  • Exhibit 126: Bushu Pharmaceuticals Ltd. - Overview
  • Exhibit 127: Bushu Pharmaceuticals Ltd. - Product / Service
  • Exhibit 128: Bushu Pharmaceuticals Ltd. - Key offerings
12.6 Clinigen Group Plc
  • Exhibit 129: Clinigen Group Plc - Overview
  • Exhibit 130: Clinigen Group Plc - Product / Service
  • Exhibit 131: Clinigen Group Plc - Key offerings
12.7 Deutsche Bahn AG
  • Exhibit 132: Deutsche Bahn AG - Overview
  • Exhibit 133: Deutsche Bahn AG - Business segments
  • Exhibit 134: Deutsche Bahn AG - Key news
  • Exhibit 135: Deutsche Bahn AG - Key offerings
  • Exhibit 136: Deutsche Bahn AG - Segment focus
12.8 Emsere B.V
  • Exhibit 137: Emsere B.V - Overview
  • Exhibit 138: Emsere B.V - Product / Service
  • Exhibit 139: Emsere B.V - Key offerings
12.9 International Bonded Couriers Inc.
  • Exhibit 140: International Bonded Couriers Inc. - Overview
  • Exhibit 141: International Bonded Couriers Inc. - Product / Service
  • Exhibit 142: International Bonded Couriers Inc. - Key offerings
12.10 Nuvisan GmbH
  • Exhibit 143: Nuvisan GmbH - Overview
  • Exhibit 144: Nuvisan GmbH - Product / Service
  • Exhibit 145: Nuvisan GmbH - Key offerings
12.11 Obvio Health USA Inc.
  • Exhibit 146: Obvio Health USA Inc. - Overview
  • Exhibit 147: Obvio Health USA Inc. - Product / Service
  • Exhibit 148: Obvio Health USA Inc. - Key offerings
12.12 Parexel International Corp.
  • Exhibit 149: Parexel International Corp. - Overview
  • Exhibit 150: Parexel International Corp. - Product / Service
  • Exhibit 151: Parexel International Corp. - Key news
  • Exhibit 152: Parexel International Corp. - Key offerings
12.13 PCI Pharma Services
  • Exhibit 153: PCI Pharma Services - Overview
  • Exhibit 154: PCI Pharma Services - Product / Service
  • Exhibit 155: PCI Pharma Services - Key offerings
12.14 PHOENIX Pharmahandel GmbH and Co KG
  • Exhibit 156: PHOENIX Pharmahandel GmbH and Co KG - Overview
  • Exhibit 157: PHOENIX Pharmahandel GmbH and Co KG - Product / Service
  • Exhibit 158: PHOENIX Pharmahandel GmbH and Co KG - Key news
  • Exhibit 159: PHOENIX Pharmahandel GmbH and Co KG - Key offerings
12.15 Piramal Enterprises Ltd.
  • Exhibit 160: Piramal Enterprises Ltd. - Overview
  • Exhibit 161: Piramal Enterprises Ltd. - Product / Service
  • Exhibit 162: Piramal Enterprises Ltd. - Key offerings
12.16 Precision Medicine Group LLC
  • Exhibit 163: Precision Medicine Group LLC - Overview
  • Exhibit 164: Precision Medicine Group LLC - Product / Service
  • Exhibit 165: Precision Medicine Group LLC - Key offerings
12.17 Vertical Pharma Resources Ltd.
  • Exhibit 166: Vertical Pharma Resources Ltd. - Overview
  • Exhibit 167: Vertical Pharma Resources Ltd. - Product / Service
  • Exhibit 168: Vertical Pharma Resources Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
  • Exhibit 169: Inclusions checklist
  • Exhibit 170: Exclusions checklist
13.3 Currency conversion rates for US$
  • Exhibit 171: Currency conversion rates for US$
13.4 Research methodology
  • Exhibit 172: Research methodology
  • Exhibit 173: Validation techniques employed for market sizing
  • Exhibit 174: Information sources
13.5 List of abbreviations
  • Exhibit 175: List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 6: Executive Summary - Chart on Market Segmentation by Type
Exhibit 7: Executive Summary - Chart on Incremental Growth
Exhibit 8: Executive Summary - Data Table on Incremental Growth
Exhibit 9: Executive Summary - Chart on Vendor Market Positioning
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
Exhibit 12: Offerings of vendors included in the market definition
Exhibit 13: Market segments
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 18: Historic Market Size - Data Table on global clinical trial supplies market 2017 - 2021 ($ million)
Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
Exhibit 34: Chart on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
Exhibit 38: Chart on Biologics industry - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Biologics industry - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Biologics industry - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Biologics industry - Year-over-year growth 2022-2027 (%)
Exhibit 42: Chart on Medical device industry - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Medical device industry - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Medical device industry - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Medical device industry - Year-over-year growth 2022-2027 (%)
Exhibit 46: Market opportunity by End-user ($ million)
Exhibit 47: Data Table on Market opportunity by End-user ($ million)
Exhibit 48: Chart on Type - Market share 2022-2027 (%)
Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
Exhibit 50: Chart on Comparison by Type
Exhibit 51: Data Table on Comparison by Type
Exhibit 52: Chart on Phase III - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Phase III - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Phase III - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Phase III - Year-over-year growth 2022-2027 (%)
Exhibit 56: Chart on Phase II - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Phase II - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Phase II - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Phase II - Year-over-year growth 2022-2027 (%)
Exhibit 60: Chart on Phase IV and BE/BA studies - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Phase IV and BE/BA studies - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Phase IV and BE/BA studies - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Phase IV and BE/BA studies - Year-over-year growth 2022-2027 (%)
Exhibit 64: Chart on Phase I - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Data Table on Phase I - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Chart on Phase I - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Phase I - Year-over-year growth 2022-2027 (%)
Exhibit 68: Market opportunity by Type ($ million)
Exhibit 69: Data Table on Market opportunity by Type ($ million)
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibit 107: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 108: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibit 113: Impact of drivers and challenges in 2022 and 2027
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
Exhibit 115: Overview on factors of disruption
Exhibit 116: Impact of key risks on business
Exhibit 117: Vendors covered
Exhibit 118: Matrix on vendor position and classification
Exhibit 119: Ancillare LP - Overview
Exhibit 120: Ancillare LP - Product / Service
Exhibit 121: Ancillare LP - Key offerings
Exhibit 122: Avantor Inc. - Overview
Exhibit 123: Avantor Inc. - Business segments
Exhibit 124: Avantor Inc. - Key offerings
Exhibit 125: Avantor Inc. - Segment focus
Exhibit 126: Bushu Pharmaceuticals Ltd. - Overview
Exhibit 127: Bushu Pharmaceuticals Ltd. - Product / Service
Exhibit 128: Bushu Pharmaceuticals Ltd. - Key offerings
Exhibit 129: Clinigen Group Plc - Overview
Exhibit 130: Clinigen Group Plc - Product / Service
Exhibit 131: Clinigen Group Plc - Key offerings
Exhibit 132: Deutsche Bahn AG - Overview
Exhibit 133: Deutsche Bahn AG - Business segments
Exhibit 134: Deutsche Bahn AG - Key news
Exhibit 135: Deutsche Bahn AG - Key offerings
Exhibit 136: Deutsche Bahn AG - Segment focus
Exhibit 137: Emsere B.V - Overview
Exhibit 138: Emsere B.V - Product / Service
Exhibit 139: Emsere B.V - Key offerings
Exhibit 140: International Bonded Couriers Inc. - Overview
Exhibit 141: International Bonded Couriers Inc. - Product / Service
Exhibit 142: International Bonded Couriers Inc. - Key offerings
Exhibit 143: Nuvisan GmbH - Overview
Exhibit 144: Nuvisan GmbH - Product / Service
Exhibit 145: Nuvisan GmbH - Key offerings
Exhibit 146: Obvio Health USA Inc. - Overview
Exhibit 147: Obvio Health USA Inc. - Product / Service
Exhibit 148: Obvio Health USA Inc. - Key offerings
Exhibit 149: Parexel International Corp. - Overview
Exhibit 150: Parexel International Corp. - Product / Service
Exhibit 151: Parexel International Corp. - Key news
Exhibit 152: Parexel International Corp. - Key offerings
Exhibit 153: PCI Pharma Services - Overview
Exhibit 154: PCI Pharma Services - Product / Service
Exhibit 155: PCI Pharma Services - Key offerings
Exhibit 156: PHOENIX Pharmahandel GmbH and Co KG - Overview
Exhibit 157: PHOENIX Pharmahandel GmbH and Co KG - Product / Service
Exhibit 158: PHOENIX Pharmahandel GmbH and Co KG - Key news
Exhibit 159: PHOENIX Pharmahandel GmbH and Co KG - Key offerings
Exhibit 160: Piramal Enterprises Ltd. - Overview
Exhibit 161: Piramal Enterprises Ltd. - Product / Service
Exhibit 162: Piramal Enterprises Ltd. - Key offerings
Exhibit 163: Precision Medicine Group LLC - Overview
Exhibit 164: Precision Medicine Group LLC - Product / Service
Exhibit 165: Precision Medicine Group LLC - Key offerings
Exhibit 166: Vertical Pharma Resources Ltd. - Overview
Exhibit 167: Vertical Pharma Resources Ltd. - Product / Service
Exhibit 168: Vertical Pharma Resources Ltd. - Key offerings
Exhibit 169: Inclusions checklist
Exhibit 170: Exclusions checklist
Exhibit 171: Currency conversion rates for US$
Exhibit 172: Research methodology
Exhibit 173: Validation techniques employed for market sizing
Exhibit 174: Information sources
Exhibit 175: List of abbreviations

Executive Summary

The research team recognizes the following companies as the key players in the global clinical trial supplies market: Avantor Inc., Bionical Emas Group, Bushu Pharmaceuticals Ltd., Catalent Inc., Clinical Services International Ltd., Clinigen Group Plc, Deutsche Bahn AG, Emsere B.V, GNH India Pharmaceuticals Ltd., International Bonded Couriers Inc., Nuvisan GmbH, Obvio Health USA Inc., Parexel International Corp., PHOENIX Pharmahandel GmbH and Co KG, Piramal Enterprises Ltd., Thermo Fisher Scientific Inc., Vertical Pharma Resources Ltd., Ancillare LP, PCI Pharma Services, and Precision Medicine Group LLC.

One of the report's analysts commented on the report, saying: 'The latest trend gaining momentum in the market is growing demand for CROS.'

According to the report, one of the major drivers for this market is the growth of the biopharmaceutical industry.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Avantor Inc.
  • Bionical Emas Group
  • Bushu Pharmaceuticals Ltd.
  • Catalent Inc.
  • Clinical Services International Ltd.
  • Clinigen Group PLC
  • Deutsche Bahn AG
  • Emsere B.V
  • GNH India Pharmaceuticals Ltd.
  • International Bonded Couriers Inc.
  • Nuvisan GmbH
  • Obvio Health USA Inc.
  • Parexel International Corp.
  • PHOENIX Pharmahandel GmbH and Co KG
  • Piramal Enterprises Ltd.
  • Thermo Fisher Scientific Inc.
  • Vertical Pharma Resources Ltd.
  • Ancillare LP
  • PCI Pharma Services
  • Precision Medicine Group LLC

Related Topics

Related Reports

Global Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Forecast 2023-2030 - Product Image

Global Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Forecast 2023-2030

  • Report
  • 184 Pages
  • Global
From
Global Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs), & Region - Forecast to 2028 - Product Image

Global Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs), & Region - Forecast to 2028

  • Report
  • 328 Pages
  • Global
From
Global Clinical Trial Supplies Market by Phase (Phase I, Phase II, Phase III), ???? (Biologic Drugs, Medical Devices, Small-Molecules), Product, Therapeutic Area, End User - Forecast 2024-2030 - Product Image

Global Clinical Trial Supplies Market by Phase (Phase I, Phase II, Phase III), ???? (Biologic Drugs, Medical Devices, Small-Molecules), Product, Therapeutic Area, End User - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From
Clinical Trial Supplies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Clinical Trial Supplies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 149 Pages
  • Global
From
Clinical Trial Supplies Global Market Report 2024 - Product Image

Clinical Trial Supplies Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.